Bluesky Facebook Reddit Email

New study reveals potential role of TLNRD1 in cerebral cavernous malformations disease

08.23.24 | Abo Akademi University

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Researchers have discovered a crucial protein, TLNRD1, that could help us better understand and treat Cerebral Cavernous Malformations (CCM) disease.

This condition causes blood-filled lesions in the brain, leading to seizures, neurological problems, and, in severe cases, strokes.

A team of scientists from Åbo Akademi University and the University of Liverpool found that a previously poorly characterized protein, TLNRD1 is an integral part of a complex of proteins essential for keeping blood vessels stable. Their study, recently published in the Journal of Cell Biology, highlights how this protein helps maintain the integrity of blood vessels in the brain.

Key Findings:

This study represents a significant step forward in understanding CCM disease identifying a new component of the CCM complex. It showcases the potential for targeted molecular therapies to improve patient outcomes. The researchers are optimistic that their work will inspire further investigations and innovations in vascular biology and neurovascular disorders.

“By uncovering the role of TLNRD1 in the CCM complex, we have identified a new target for therapeutic intervention in CCM disease. 75% of familial CCM cases are caused by mutations in the three known CCM genes, and we are currently exploring the idea that TLNRD1 mutations might link to CCM disease. This discovery advances our understanding of vascular biology and offers hope for developing effective treatments,” said Guillaume Jacquemet , one of the lead researchers.

Publication: Ball et al., 2024. “TLNRD1 is a CCM complex component and regulates endothelial barrier integrity.” Journal of Cell Biology. Access the full article here .

About the InFLAMES Research Flagship Center: The InFLAMES Research Flagship Center is a joint initiative of the University of Turku and Åbo Akademi University, aiming to integrate immunological and immunology-related research to develop new diagnostic and therapeutic tools for precision medicine.

Prof. Guillaume Jacquemet, Åbo Akademi University
e-mail: Guillaume.Jacquemet@abo.fi
telephone: +358 50 3235 606

Prof. Benjamin T. Goult, University of Liverpool
e-mail: B.T.Goult@liverpool.ac.uk

Journal of Cell Biology

10.1083/jcb.202310030

Skip Nav Destination Article|July 16 2024 TLNRD1 is a CCM complex component and regulates endothelial barrier integrity

Keywords

Article Information

Contact Information

Pamela Fristrom
Abo Akademi University
pamela.fristrom@abo.fi

Source

How to Cite This Article

APA:
Abo Akademi University. (2024, August 23). New study reveals potential role of TLNRD1 in cerebral cavernous malformations disease. Brightsurf News. https://www.brightsurf.com/news/8X5OVDY1/new-study-reveals-potential-role-of-tlnrd1-in-cerebral-cavernous-malformations-disease.html
MLA:
"New study reveals potential role of TLNRD1 in cerebral cavernous malformations disease." Brightsurf News, Aug. 23 2024, https://www.brightsurf.com/news/8X5OVDY1/new-study-reveals-potential-role-of-tlnrd1-in-cerebral-cavernous-malformations-disease.html.